Customized research for RLMD vs. CTRV!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for RLMD vs. CTRV.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Relmada Therapeutics, Inc. vs. ContraVir Pharmaceuticals, Inc.

Industry Match! Industry of Both RLMD and CTRV:

Health Care/Life Sciences

RLMD
Data Last Updated: More than a wk ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 395.304M


P/E: N/A

P/S: N/A

Q P/B: 66.1

Y Rev: -

Q Rev: -

Beta: -0.06

RLMD Share Stats

Outstanding Shares

14.67M

Float Shares

13.28M

Percent of Float Short

9.58%

RLMD Insider Stats

Percent Outstanding Insider Ownership

5.9%

Percent Outstanding Institution Ownership

4.81%

RLMD Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

RLMD in Pulse Portal

Stream of Posts

RLMD Symbol Page

Share RLMD Insights

Express Sentiment

'Buy' or 'Sell' RLMD

RLMD Profile

CEO

Dr. Sergio Traversa

Exchange

Nasdaq

Employees

4.00

About

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and...

RLMD Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(17.32M)

Cash Flow Statement

Change in Cash / Investments

6.98M

Balance Sheet

Cash / Investments

9.22M

Short Term Debt

364,204

Long Term Debt

None

Total Current Assets

9.98M

Total Current Liabilities

2.61M

Total Assets

10.22M

Total Liabilities

2.61M

Stockholder Equity

7.61M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(3.67M)

Cash Flow Statement

Q Change in Cash / Investments

(1.37M)

Balance Sheet

Q Cash / Investments

7.85M

Q Short Term Debt

255,925

Q Long Term Debt

None

Q Total Current Assets

8.3M

Q Total Current Liabilities

2.54M

Q Total Assets

8.51M

Q Total Liabilities

2.54M

Q Stockholder Equity

5.98M

RLMD Charts

10-Year Chart

RLMD 10-Year Chart

5-Year Chart

RLMD 5-Year Chart

1-Year Chart

RLMD 1-Year Chart

6-Month Chart

RLMD 6-Month Chart

3-Month Chart

RLMD 3-Month Chart

1-Month Chart

RLMD 1-Month Chart

1-Day Chart

RLMD 1-Day Chart

CTRV
Data Last Updated: More than 6 mos ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 6.138M


P/E: N/A

P/S: N/A

Q P/B: 9.44

Y Rev: -

Q Rev: -

Beta: -0.12

CTRV Share Stats

Outstanding Shares

3.40M

Float Shares

15.85M

Percent of Float Short

1.02%

CTRV Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

CTRV Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

CTRV in Pulse Portal

Stream of Posts

CTRV Symbol Page

Share CTRV Insights

Express Sentiment

'Buy' or 'Sell' CTRV

CTRV Profile

CEO

Dr. Gary S. Jacob

Exchange

Nasdaq

Employees

14.00

About

ContraVir Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways...

CTRV Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(9.45M)

Cash Flow Statement

Change in Cash / Investments

(3.12M)

Balance Sheet

Cash / Investments

2.83M

Short Term Debt

1.44M

Long Term Debt

None

Total Current Assets

2.97M

Total Current Liabilities

2.85M

Total Assets

8.19M

Total Liabilities

6.21M

Stockholder Equity

1.98M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(1.98M)

Cash Flow Statement

Q Change in Cash / Investments

(1.15M)

Balance Sheet

Q Cash / Investments

1.68M

Q Short Term Debt

2.09M

Q Long Term Debt

None

Q Total Current Assets

1.91M

Q Total Current Liabilities

3.46M

Q Total Assets

7.9M

Q Total Liabilities

7.26M

Q Stockholder Equity

645,459

CTRV Charts

10-Year Chart

CTRV 10-Year Chart

5-Year Chart

CTRV 5-Year Chart

1-Year Chart

CTRV 1-Year Chart

6-Month Chart

CTRV 6-Month Chart

3-Month Chart

CTRV 3-Month Chart

1-Month Chart

CTRV 1-Month Chart

1-Day Chart

CTRV 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon